Manchester Capital Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.11M | Sell |
4,160
-10
| -0.2% | -$2.71K | 0.16% | 82 |
|
|
2025
Q4 | $1.05M | Buy |
4,170
+9
| +0.2% | +$2.39K | 0.14% | 92 |
|
|
2025
Q3 | $1.19M | Hold |
4,161
| – | – | 0.16% | 87 |
|
|
2025
Q2 | $1.09M | Hold |
4,161
| – | – | 0.14% | 106 |
|
|
2025
Q1 | $968K | Sell |
4,161
-34
| -0.8% | -$8.25K | 0.12% | 119 |
|
|
2024
Q4 | $962K | Buy |
4,195
+5
| +0.1% | +$1.15K | 0.11% | 117 |
|
|
2024
Q3 | $936K | Buy |
4,190
+23
| +0.6% | +$5.05K | 0.11% | 123 |
|
|
2024
Q2 | $848K | Buy |
4,167
+11
| +0.3% | +$2.24K | 0.1% | 129 |
|
|
2024
Q1 | $908K | Sell |
4,156
-3
| -0.1% | -$661 | 0.11% | 125 |
|
|
2023
Q4 | $945K | Buy |
4,159
+45
| +1% | +$9.45K | 0.13% | 107 |
|
|
2023
Q3 | $827K | Sell |
4,114
-732
| -15% | -$154K | 0.12% | 107 |
|
|
2023
Q2 | $1M | Sell |
4,846
-250
| -5% | -$48.5K | 0.13% | 94 |
|
|
2023
Q1 | $1M | Hold |
5,096
| – | – | 0.13% | 106 |
|
|
2022
Q4 | $1.03M | Buy |
5,096
+901
| +21% | +$176K | 0.15% | 91 |
|
|
2022
Q3 | $738K | Sell |
4,195
-72
| -2% | -$14.7K | 0.13% | 87 |
|
|
2022
Q2 | $859K | Hold |
4,267
| – | – | 0.15% | 83 |
|
|
2022
Q1 | $967K | Hold |
4,267
| – | – | 0.14% | 92 |
|
|
2021
Q4 | $1.15M | Hold |
4,267
| – | – | 0.15% | 92 |
|
|
2021
Q3 | $1.03M | Hold |
4,267
| – | – | 0.14% | 96 |
|
|
2021
Q2 | $1.01M | Sell |
4,267
-1,845
| -30% | -$420K | 0.14% | 108 |
|
|
2021
Q1 | $1.34M | Hold |
6,112
| – | – | 0.2% | 80 |
|
|
2020
Q4 | $1.07M | Hold |
6,112
| – | – | 0.17% | 91 |
|
|
2020
Q3 | $989K | Hold |
6,112
| – | – | 0.15% | 89 |
|
|
2020
Q2 | $872K | Hold |
6,112
| – | – | 0.12% | 109 |
|
|
2020
Q1 | $664K | Hold |
6,112
| – | – | 0.11% | 117 |
|
|
2019
Q4 | $888K | Hold |
6,112
| – | – | 0.1% | 122 |
|
|
2019
Q3 | $882K | Hold |
6,112
| – | – | 0.1% | 107 |
|
|
2019
Q2 | $908K | Hold |
6,112
| – | – | 0.12% | 99 |
|
|
2019
Q1 | $803K | Sell |
6,112
-437
| -7% | -$53.8K | 0.1% | 110 |
|
|
2018
Q4 | $1.01M | Hold |
6,549
| – | – | 0.15% | 66 |
|
|
2018
Q3 | $977K | Hold |
6,549
| – | – | 0.14% | 73 |
|
|
2018
Q2 | $1.01M | Hold |
6,549
| – | – | 0.15% | 66 |
|
|
2018
Q1 | $910K | Sell |
6,549
-436
| -6% | -$64K | 0.15% | 70 |
|
|
2017
Q4 | $957K | Hold |
6,985
| – | – | 0.14% | 66 |
|
|
2017
Q3 | $906K | Hold |
6,985
| – | – | 0.14% | 61 |
|
|
2017
Q2 | $925K | Hold |
6,985
| – | – | 0.15% | 64 |
|
|
2017
Q1 | $861K | Hold |
6,985
| – | – | 0.14% | 73 |
|
|
2016
Q4 | $770K | Hold |
6,985
| – | – | 0.12% | 85 |
|
|
2016
Q3 | $825K | Hold |
6,985
| – | – | 0.12% | 79 |
|
|
2016
Q2 | $782K | Hold |
6,985
| – | – | 0.11% | 89 |
|
|
2016
Q1 | $703K | Hold |
6,985
| – | – | 0.1% | 89 |
|
|
2015
Q4 | $742K | Hold |
6,985
| – | – | 0.1% | 87 |
|
|
2015
Q3 | $651K | Hold |
6,985
| – | – | 0.11% | 77 |
|
|
2015
Q2 | $727K | Hold |
6,985
| – | – | 0.12% | 82 |
|
|
2015
Q1 | $756K | Sell |
6,985
-233
| -3% | -$24K | 0.12% | 70 |
|
|
2014
Q4 | $669K | Hold |
7,218
| – | – | 0.08% | 109 |
|
|
2014
Q3 | $631K | Buy |
7,218
+873
| +14% | +$78.9K | 0.08% | 108 |
|
|
2014
Q2 | $558K | Hold |
6,345
| – | – | 0.07% | 131 |
|
|
2014
Q1 | $535K | Hold |
6,345
| – | – | 0.09% | 131 |
|
|
2013
Q4 | $498K | Sell |
6,345
-233
| -4% | -$19.9K | 0.08% | 147 |
|
|
2013
Q3 | $560K | Sell |
6,578
-145
| -2% | -$12.2K | 0.1% | 113 |
|
|
2013
Q2 | $578K | Buy |
+6,723
| New | +$558K | 0.11% | 94 |
|
Other funds holding LH
VCM
VPM
Manchester Capital Management's LH Position: Q1 2026 in Review
Manchester Capital Management reduced its Labcorp (LH) stake by 0.24% in Q1 2026, selling an estimated $2.71K and leaving 4,160 shares worth $1.11M. The position accounts for 0.16% of the portfolio, ranked #82.
Manchester Capital Management first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.34M in Q1 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Manchester Capital Management held 4,160 shares of Labcorp worth $1.11M as of Q1 2026.
- Manchester Capital Management sold 10 Labcorp shares in Q1 2026, an estimated $2.71K.
- Labcorp made up 0.16% of Manchester Capital Management's portfolio in Q1 2026, its #82 holding.
- Manchester Capital Management first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
- Manchester Capital Management's Labcorp position peaked at $1.34M in Q1 2021.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.